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Background
Aggregation of therapeutic antibodies could be generated
at different steps of the manufacturing process, posing
the problem for quality control of produced antibodies. It
has been well known that secreted antibodies from
recombinant mammalian cells into culture medium can
aggregate due to the physicochemical stresses such as
media pH and osmolality, cultivation temperature [1,2].
The antibody aggregation during the cell culture process
is difficult to suppress because the cell culture conditions
for antibody production are generally optimized for cell
culture and growth and not for suppressing the aggregate
formation. Here we show the novel strategy to suppress
the antibody aggregation; application of chemical chaper-
one to the cell culture process. It is well established that
an addition of some cosolutes serves as chemical chaper-
one to suppress the protein aggregation. Trehalose, non-
reducing sugar formed from two glucose units with a-1,1
linkage, is known as an effective chemical chaperone. In
this study, we investigated the anti-aggregation effect of
trehalose in the culture process of recombinant Chinese
hamster ovary cell (CHO) line producing Ex3-humanized
IgG-like bispecific single-chained diabody with Fc (Ex3-
scDb-Fc). Ex3-scDb-Fc shows the remarkable anti-tumor
activity based on anti-EGFR and anti-CD3 bispecificity
[3]. However, our in-house results showed that Ex3-
scDb-Fc shows aggregation tendency, demonstrating the
necessity of developing a bioprocess for suppressing the
aggregation of the bispecific diabody.
Materials and methods
CHO Top-H cell line producing the Ex3-scDb-Fc [4]
was cultivated in 500mL Erlenmeyer flask and 2L-glass
bioreactor with serum-free medium containing 150mM
trehalose. Viable cell densities and antibody concentra-
tions were determined with Vi-Cell XR™ cell viability
analyzer (Beckman Coulter) and by ELISA, respectively.
Ex3-scDb-Fc was purified with Hi-Trap protein A col-
umn (GE Healthcare). 1M Arg-HCl (pH4.2) was used as
eluting solution, which make it possible to prevent the
aggregation of the antibody in the affinity purification
process. Antibody aggregation was analyzed by sepha-
cryl S-300 column (GE healthcare). Solution structure
of Ex3-scDb-Fc was assessed by circular dichroism
spectroscopy.
Results and discussion
Cell culture performance in trehalose containing
medium
We cultivated CHO Top-H cell line in 150mM trehalose
containing medium. The media osmolalities with and
without trehalose (150 mM) were 480 mOsm/kg and 319
mOsm/kg, respectively. Estimated kinetic parameters of
cell culture are listed in Table 1. Cell culture in Erlen-
meyer flasks demonstrated that cell growth was strongly
affected by trehalose; the specific cell growth rate and the
maximum cell density were decreased compared to those
in the absence of trehalose. On the other hand, both the
specific antibody production rate and volumetric produc-
tion were largely enhanced by trehalose addition. The
results in Erlenmeyer flask mentioned above were repro-
duced in 2L-glass bioreactor culture. Observed properties
of the cell culture in the presence of trehaose, suppressed
cell growth and enhanced antibody production, were simi-
lar to those reported for mammalian cell cultures under
hyperosmotic condition [5], although the underlying
mechanisms responsible for the enhanced antibody pro-
duction are largely unknown.
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Anti-aggregation effects by trehalose during the cell
culture process
The scDb-Fc was purified from the culture supernatant by
protein A affinity chromatography, and the aggregation
states were analyzed by size exclusion chromatography.
We observed the 3 states of scDb-Fc, monomer, dimer,
and large aggregates, which were included in the culture
supernatant when harvested (Figure 1). The peak area of
the large aggregates in the presence of trehalose was one-
third that in the absence of trehalose, indicating that tre-
halose suppressed the formation of large aggregates in the
CHO cell culture. Circular dichroism (CD) spectroscopy
showed that the large aggregates were misfolded state with
non-native b-strand. Trehalose is expected to suppress the
accumulation of misfolded state and the intermolecular
interactions leading to the aggregate formation in cell
culture.
Conclusions
We demonstrated the potential application of chemical
chaperon in the culture of antibody-producing mamma-
lian cells. Trehalose can be incorporated in the culture
media for CHO cells, and can suppress the antibody
aggregation, especially high-order aggregates. In addi-
tion, trehalose may be involved in the enhancement of
antibody production.
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Without trehalose 3.07 ± 0.18 a 0.39 ± 0.02 a
150mM trehalose 1.51 ± 0.04 a 1.55 ± 0.03 a
a Mean ± S.D. (n = 3).
Figure 1 Size-exclusion chromatography showing the
aggregation status of Ex3-scDb-Fc.
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